188 related articles for article (PubMed ID: 23822952)
1. Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice.
Raver SM; Haughwout SP; Keller A
Neuropsychopharmacology; 2013 Nov; 38(12):2338-47. PubMed ID: 23822952
[TBL] [Abstract][Full Text] [Related]
2. Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.
Raver SM; Keller A
Neuropharmacology; 2014 Nov; 86():161-73. PubMed ID: 25036610
[TBL] [Abstract][Full Text] [Related]
3. Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity.
Mouro FM; Ribeiro JA; Sebastião AM; Dawson N
J Neurochem; 2018 Oct; 147(1):71-83. PubMed ID: 29989183
[TBL] [Abstract][Full Text] [Related]
4. An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity.
Lovelace JW; Corches A; Vieira PA; Hiroto AS; Mackie K; Korzus E
Neuropharmacology; 2015 Dec; 99():242-55. PubMed ID: 25979486
[TBL] [Abstract][Full Text] [Related]
5. Chronic Exposure to WIN55,212-2 During Adolescence Alters Prefrontal Dopamine Turnover and Induces Sensorimotor Deficits in Adult Rats.
Abboussi O; Andaloussi ZL; Chris AD; Taghzouti K
Neurotox Res; 2020 Oct; 38(3):682-690. PubMed ID: 32757167
[TBL] [Abstract][Full Text] [Related]
6. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
Maggo S; Ashton JC
J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
[TBL] [Abstract][Full Text] [Related]
7. Chronic and acute adenosine A
Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
[TBL] [Abstract][Full Text] [Related]
8. Developmental effects of cannabinoids on zebrafish larvae.
Akhtar MT; Ali S; Rashidi H; van der Kooy F; Verpoorte R; Richardson MK
Zebrafish; 2013 Sep; 10(3):283-93. PubMed ID: 23789728
[TBL] [Abstract][Full Text] [Related]
9. Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity.
Campolongo P; Morena M; Scaccianoce S; Trezza V; Chiarotti F; Schelling G; Cuomo V; Roozendaal B
Neuropsychopharmacology; 2013 Jun; 38(7):1276-86. PubMed ID: 23340520
[TBL] [Abstract][Full Text] [Related]
10. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.
Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
Schneider M; Schömig E; Leweke FM
Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache.
Kopruszinski CM; Navratilova E; Vagnerova B; Swiokla J; Patwardhan A; Dodick D; Porreca F
Cephalalgia; 2020 Jan; 40(1):68-78. PubMed ID: 31311288
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212-2 depend on mGlu5 receptor signalling.
Manduca A; Servadio M; Melancia F; Schiavi S; Manzoni OJ; Trezza V
Br J Pharmacol; 2020 Jan; 177(2):449-463. PubMed ID: 31658362
[TBL] [Abstract][Full Text] [Related]
14. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
Saez TM; Aronne MP; Caltana L; Brusco AH
J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778
[TBL] [Abstract][Full Text] [Related]
15. Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats.
Suenaga T; Ichitani Y
Behav Brain Res; 2008 Jul; 190(2):248-52. PubMed ID: 18374994
[TBL] [Abstract][Full Text] [Related]
16. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.
Leweke FM; Schneider M
Int J Neuropsychopharmacol; 2011 Feb; 14(1):43-51. PubMed ID: 20678304
[TBL] [Abstract][Full Text] [Related]
17. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G
Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.
Ferraro L; Tomasini MC; Beggiato S; Gaetani S; Cassano T; Cuomo V; Amoroso S; Tanganelli S; Antonelli T
J Neural Transm (Vienna); 2009 Aug; 116(8):1017-27. PubMed ID: 19533296
[TBL] [Abstract][Full Text] [Related]
19. It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis.
Skosnik PD; Cortes-Briones JA; Hajós M
Biol Psychiatry; 2016 Apr; 79(7):568-77. PubMed ID: 26850792
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.
Kucewicz MT; Tricklebank MD; Bogacz R; Jones MW
J Neurosci; 2011 Oct; 31(43):15560-8. PubMed ID: 22031901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
